for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Novavax says vaccine efficacy preserved in participants receiving influenza, COVID-19 vaccines

June 14 (Reuters) - Novavax Inc said on Monday vaccine efficacy appeared to be preserved in those receiving an approved influenza vaccine along with its COVID-19 vaccine candidate compared to those vaccinated with the COVID-19 vaccine candidate alone. (Reporting by Amruta Khandekar)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up